Skip to content

Clinical trials

Withdrawn Recurrence trials in China

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Recurrence Status: Withdrawn Country / region: China Clear all

13 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20141
20162
20171
20181
20221
20242
20253
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Withdrawn13

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Beijing Boren Hospital2
Sun Yat-sen University2
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology2
BioNova Pharmaceuticals (Shanghai) LTD.1
Celgene1
Institute of Hematology & Blood Diseases Hospital, China1
Nanjing Legend Biotech Co.1
Peking University People's Hospital1
Shanghai Unicar-Therapy Bio-medicine Technology Co.,Ltd1
Zhi Yang1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Recurrence13
Multiple Myeloma3
Autoimmune Diseases2
Leukemia, Myeloid, Acute2
Lupus Erythematosus, Systemic2
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis1
Breast Neoplasms1
Colorectal Neoplasms1
Glioma1
Immunoglobulin G4-Related Disease1

Trials

Showing 1 to 13 of 13. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.